BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mukhtar RA, Holland M, Sieber DA, Wen KW, Rugo HS, Kadin ME, Bean GR. Synchronous Breast Implant-associated Anaplastic Large Cell Lymphoma and Invasive Carcinoma: Genomic Profiling and Management Implications. Plast Reconstr Surg Glob Open 2019;7:e2188. [PMID: 31321184 DOI: 10.1097/GOX.0000000000002188] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Riis M, Csanaky G, Lehne G, Tangerud A. Anaplastic large cell lymphoma, ALK-negative of the breast diagnosed a short time after removal of breast implant in a patient with breast carcinoma: diagnostic and therapeutic considerations. BMJ Case Rep 2022;15:e248232. [PMID: 35236698 DOI: 10.1136/bcr-2021-248232] [Reference Citation Analysis]
2 Deva AK, Turner SD, Kadin ME, Magnusson MR, Prince HM, Miranda RN, Inghirami GG, Adams WP Jr. Etiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): Current Directions in Research. Cancers (Basel) 2020;12:E3861. [PMID: 33371292 DOI: 10.3390/cancers12123861] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]